Skip to main content

Role of lipocalin-2 in surgery-induced cognitive decline in mice: a signal from neuron to microglia



Perioperative neurocognitive disorders (PNDs) are common complications observed among surgical patients. Accumulating evidence suggests that neuroinflammation is one of the major contributors to the development of PNDs, but the underlying mechanisms remain unclear.


qPCR and ELISA analysis were used for detecting LCN2 and cytokine levels. cx3cr1CreER/−:: R26iDTR/− crossed mouse line was used for microglia depletion; intracranial injection of recombinant LCN2 (rLCN2) and adeno-associated viruses (AAV)-mediated shRNA silencing approaches were used for gain and loss of function, respectively. Combing with in vitro microglia cell culture, we have studied the role of LCN2 in surgery-induced cognitive decline in mice.


We revealed that Lcn2 mRNA and protein levels were greatly increased in mouse hippocampal neurons after surgery. This surgery-induced elevation of LCN2 was independent of the presence of microglia. Gain of function by intracranial injection of rLCN2 protein into hippocampus disrupted fear memory in naive mice without surgery. Conversely, silencing LCN2 in hippocampus by AAV-shRNA protected mice from surgery-induced microglia morphological changes, neuroinflammation and cognitive decline. In vitro, application of rLCN2 protein induced the expression of several pro-inflammatory cytokines in both BV-2 and primary microglia culture.


These data suggest LCN2 acts as a signal from neuron to induce proinflammatory microglia, which contributes to surgery-induced neuroinflammation and cognitive decline in mice.


Memory, attention and other cognitive impairments following major surgical procedures are common complications experienced by surgical patients, which are now termed as perioperative neurocognitive disorders (PNDs) [1,2,3]. The incidence of PNDs is reported up to around 5.7%- 54.3% in surgical patients [4, 5]. People who suffer from PNDs are at risk of poor surgical outcomes such as increased mortality [6] and decreased quality of life [7]. Moreover, PNDs also have a synergistic relationship with neurodegenerative conditions before surgery [8,9,10], making their impact even more concerning.

Surgical procedures are associated with robust innate immune activation [11], which could lead to neuroinflammation [12, 13]. Accumulating clinical and preclinical evidence suggest that neuroinflammation is one of the major contributors to the development of PNDs [12, 14,15,16]. In surgical patients, the increase of inflammatory cytokines in cerebral spinal fluid (CSF) has been repeatedly described [17,18,19,20]. In addition, rodent studies reveal that surgical trauma-released alarmins could activate the innate immune system, including the activation of immune cells and the increased production of proinflammatory cytokines [21]; these peripheral immune-related events lead to the disruption of the blood–brain barrier and subsequent recruitment of inflammatory monocytes into brain [22], these together with the subsequently activated microglia [23, 24], disrupt cognitive functions [22, 25].

Lipocalin-2 (LCN2, 26kD) is a small secreted protein [26] and initially described as an anti-bacterial protein for clearing the pathogen [27]. In normal adult brain, the expression of LCN2 is very low and becomes upregulated during injury or neurodegenerative conditions [28]. Our previous genome-wide RNA-seq analysis showed that Lcn2 was one of the top upregulated genes in mouse hippocampus after surgery [29]. A prior study found an association between elevation of LCN2 levels and cognitive dysfunction after surgery in rats [30]. Consistently, elevation of LCN2 levels have also been observed in plasma and CSF of surgical patients [31]. Several clinical studies have assessed the potential value of LCN2 as a biomarker for neurodegenerations including vascular dementia [32], mild cognitive impairment [33] or preclinical stage of Alzheimer’s disease [34]. However, in the context of sterile surgery evoked conditions, the precise role of LCN2 is unclear. Therefore, we sought to address the role of LCN2 in surgery-induced cognitive decline.

Materials and methods


Twelve- to sixteen-week-old C57BL/6J male mice, and cx3cr1CreER (JAX stock: 021160) and Rosa26iDTR (JAX stock: 007900) mice were used in this study (Neonatal P1 C57BL/6 J mice was used for primary microglia cell culture only). A total of ~ 250 adult mice and ~ 30 neonatal mice were used in this study. Mice were housed in polypropylene cages and maintained at 25 °C under reverse phase 12-h light–dark cycle with ad libitum access to water and rodent chow. Animals were tagged and randomly allocated to each group before any procedures. All procedures were carried out with the approval of the Animal Care Committee of the First affiliated Hospital at Zhejiang University.

Tibial fracture surgery

As previously reported[29], surgery was consisted of an aseptic open tibial fracture with intramedullary fixation performed under general anesthesia, including 1.5% isoflurane (RWD Life Science, Shenzhen, China) in 800 mL/min O2 using a rodent inhalation anesthesia apparatus (MIDTRX VIP2000, Midmark, Dayton, OH, USA). Briefly, the left hind limb was disinfected. Following the skin incision, a 28G needle (~ 0.38 mm) was inserted into the tibial intramedullary canal. Osteotomy was then performed at the junction of the middle and distal thirds of the tibia. The fixation needle remained in situ and be cut flush with the tibial cortex. After producing the fracture, skin was closed with 5–0 Vicryl sutures (Monocryl; Ethicon Inc, Somerville, NJ); thereafter, animals were allowed to recover spontaneously from anesthesia. During surgery and recovery, body temperature was maintained at 37 °C with a warming pad. The entire procedure from the induction of anesthesia to the end of surgery took less than 15 min. Tramadol (30 mg/kg) was administered intraperitoneally daily for analgesia. Control (sham-treated) mice received same anesthesia and analgesia as for tibial fracture surgery.

Trace-fear conditioning (TFC) test

TFC test was used to assess learning and memory in mice[29]. Freezing behavior is an indicator of aversive memory which is evoked by contextual cues related to a fear-inducing stimulus–response pairing learned during training. The extent of this learning (contextual fear) was recorded in a TFC chamber (Shanghai XinRuan Information Technology Co., Ltd, Shanghai, China). Memory impairment was indicated by a decrease in freezing time.


Before start of behavioral tests, mice were habituated to handling by the researcher for 3 days. In each day, mice were handled by the researcher for 2 min in the experimental room. On the training day, mice were placed in the TFC chamber and allowed to explore for 100 s. Mice were then exposed to an auditory cue (75–80 Db, 5 kHz, conditional stimulus) for 20 s, followed 20 s later by a 2 s foot shock (0.8 mAmp; unconditional stimulus). The tone and foot-shock pairing were repeated with an inter-trial interval of 100 s. After training, mice were allowed to remain in the testing chamber for 1 min before returning to the home cage.

Contextual testing

Three days after the training session, mice were placed back in the same TFC chamber without any tone or shock for 5 min. Video tracking system recorded the time spent freezing as a fraction of total time in the chamber.

Novel object recognition test (NOR test)

The Novel Object Recognition task was used to evaluate general cognitive function. This test was based on the spontaneous tendency of rodents to spend more time exploring novel object than a familiar one. The NOR test was conducted in an open field arena with two kinds of objects different in shape and appearance, but were generally consistent in height and volume. Behavior was videotaped and recorded by Anymaze software (Stoelting Co., IL, USA). Mice were habituated to handling by the researcher for 3 days before the start of behavioral tests. Animals were exposed to the arena with two identical objects placed in opposite corners for 10 min. 24 h later, mice were returned to the testing environment, where one of the sample objects was replaced by a novel object that different from familiar object in shape and texture for 5 min. The testing session was scored by an experienced researcher who was blinded to the experimental condition. Animals were scored as exploring an object when the animal spent with its head and nose oriented toward and within 2 cm of the object. Accidentally touching, sitting or standing on the object were not considered exploratory activity. The discrimination ratio was calculated as the time spent exploring the novel object divided by the total time spent with both novel and familiar objects. Higher ratio indicates better recognition performance.

Cytokine measurement

Whole blood was collected by ventricle while mice were under deep anesthesia. Blood samples were centrifuged at 3,000 rcf/min for 15 min, serum was then collected and stored at −20 °C until assayed. Then mice were immediately perfused with saline and hippocampus tissues were then rapidly extracted and disrupted by sonication in NP-40 lysis buffer (50 mM Tris, PH 7.4, 150 nM NaCl, 1% NP-40, 0.1% Triton X-100 and 0.1% SDS) containing protease inhibitors (Beyotime Biotech, China). The homogenized material was centrifuged at 20,000g for 15 min, and the cleared supernatant was collected for analysis. Total protein levels in homogenates were determined by the BCA assay (Beyotime Biotech, China). IL-6 and LCN2 protein levels were measured using the corresponding Mouse ELISA kit (R&D systems, USA), respectively. Samples were processed according to the manufacturer’s instructions.

MACS (magnetic activated cell sorting)

The hippocampus was dissected and stored in 1 mL cold HBSS buffer (hippocampus from 5 mice for Sham and Surgery group, respectively). The hippocampus was minced and dissociated in 8 mL of a mixture containing collagenase IV (5 mg/ml), DNase I (5 mg/ml) and 5% FBS, followed by bathing in water at 37 °C for 30 min. Cell suspension was then filtered through 70 µm cell strainer (BD Falcon, USA). Myelin debris was removed by using Myelin Removal Beads II (Miltenyi Biotec, Germany). Cell suspension was centrifuged at 300 g/min for 10 min then resuspended in 0.5% BSA. After incubating with anti-CD11b microbeads (Miltenyi Biotec, Germany) on ice for 15 min, CD11b+ and CD11b cells were isolated by MiniMACS separator (Miltenyi Biotec, Germany) according to the manufacturer’s instructions.

Microglia depletion

To deplete microglia, cx3cr1CreER± mice were crossed with Rosa26iDTR± mice. cx3cr1CreER±::R26iDTR± mice were orally gavaged with tamoxifen (0.35 mg/g body weight, dissolved in corn oil) or corn oil (for control group) once daily for 3 days, which induces the expression diphtheria toxin receptor (DTR) in cx3cr1-positive cells. As microglia are self-renewing with a slow turnover rate (months to years) as compared with that of cx3cr1-positive monocytes (< 1 week), only microglia continue to express DTR weeks after tamoxifen administration [35, 36]. Four weeks after tamoxifen treatment, mice were treated with diphtheria toxin (1 µg per mice, sigma) via intraperitoneal (ip) injection once daily for 3 days.

rLCN2 protein and viral intracranial injection.

rLCN2 protein intracranial injection 12-week-old mice were anesthetized under 1.5% isoflurane, and cannulas were implanted in CA1 region bilaterally (AP: −2.5, ML: ± 2.0, DV: −1.8). The cannula assembly was secured to the skull with dental cement, and mice were allowed to recover for 3 weeks. After TFC training, mice were immediately anesthetized under 1.5% isoflurane, and mouse rLCN2 (250 µg/µL, 500 nL, dissolved in PBS buffer, R&D systems, USA) was injected bilaterally using a 10μL syringe with a 30-guage metal needle (Hamilton Instruments) at a slow rate manually. After injection, the needle was left in place for another 5 min and then withdrawn slowly. Control group received vesicle. The mice were killed after behavior test and the location of injection site was examined by microscopy.

Viral intracranial injection

To knockdown of LCN2, AAV viral delivery of shRNA was conducted. Constructs were generated including LCN2-AAV (pAKD-CMV-bBlobin-eGFP-H1-shRNA-LCN2, 6.25 × 1012 GC/mL titer, Obio technology corp, Shanghai, sequence listed in Additional file 3: Table S2) and Control-AAV (pAKD-CMV-bBlobin-eGFP-H1-shRNA-Control, 8.0 × 1012 GC/mL titer, Obio technology corp, Shanghai). For virus injection, 12-week-old mice were anesthetized under 1.5% isoflurane. After a small craniotomy was performed, 200 nL virus was delivered (AP: −2.5, ML: ± 2.0, DV: −1.8) using a 10 μL syringe with a 30-guage metal needle (Hamilton Instruments). The flow rate (50 nL/min) was controlled by an injection pump. After injection, the needle was left in place for another 10 min and then withdrawn slowly. Knockdown efficiency was assessed by measuring Lcn2 mRNA and protein expression in the hippocampus 3 weeks after the injection of LCN2-AAV or Control-AAV. The location of eGFP expression (infection efficiency of virus) was also examined by fluorescent microscopy. Only mice with correct injection locations and efficient viral expression were used for further analysis.

Cell culture (BV2 microglia cell line and mouse primary microglia)

BV2 microglia cell line (ATCC No. CRL1834) was purchased from the Institute of Basic Medical Sciences, Chinese Academy of Science. Cells were maintained in high glucose DMEM supplemented with 10% FBS and 1% penicillin/streptomycin under humidified 5% CO2 air environment at 37 ºC. Mouse primary microglia cultures were obtained from the cortex of neonatal C57BL/6 J mice (P1). In brief, mouse forebrains were incubated in 0.25% trypsin for 15 min at 37 ºC, and reaction was stopped by addition of the culture medium (DMEM with 10% FBS, 1% penicillin/streptomycin). Then the cortices were dissociated by repeated up- and down-pipetting with a 5 ml pipette. The resulting cell suspension was centrifuged at 700 rcf/min for 5 min. The pellet was triturated with culture medium, passed through a 70-μM nylon cell strainer, and then centrifuged again. Then resuspended cells were seeded in T-75 flasks in culture medium at 37 ºC with 5% CO2. Two weeks later, culture flasks were shaken for 1 h at 250 rpm/min on an orbital shaker (37 ºC) to harvest microglia. The medium containing detached microglia was collected and immediately centrifuged for 10 min at 1000rcf/min. Cells was resuspended with fresh culture medium and seeded (3.5 × 105 cells/well on a 6-well plate). The purity of the microglial cultures was > 95% as determined by immuno-histochemistry with Iba-I antibody. Mycoplasma contamination PCR tests were performed prior to experiment.

rLCN2 treatment in vitro

Twenty-four hours after seeding, rLCN2 protein (R&D System, USA) was added into culture medium and the final concentration was 500 ng/mL. Cell lysate and culture medium were collected at 6 h.


Total RNA was extracted from hippocampus of mice or cells by Trizol followed by using RNA extraction kit (Tiangen Biotech, Beijing, China). Primer sequences are listed in Additional file 2: Table S1. qRT-PCR was performed on a CFX 96 real-time PCR thermocycler (Bio-Rad Lab, CA, USA). For amplification, SYBR Premix Ex Taq II (Takara Bio Inc., Otsu, Japan) was used as instructed in the manufacturer's manual. Relative changes of mRNA expression were analyzed with the 2–ΔΔCt method with gapdh as an internal reference. These standardized data were used to calculate fold-changes in gene expression. All real-time PCR amplifications were performed in triplicates.

Immunofluorescence histochemistry.

Mice were killed and perfused with saline then followed by 4% paraformaldehyde. Brains were removed and post fixed at 4 °C overnight. Brains were dehydrated in sucrose solution (30%) for 24 h at least. Coronal sections (35 μm thick) were cut on a cryostat and stored in cryoprotectant at −20 ºC. In brief, sections were washed in PBS buffer, followed by incubation with blocking medium (PBS buffer containing 10% donkey serum, 1% bovine albumin and 0.1% Triton X-100) for 1 h at room temperature. Then the sections were incubated with primary antibodies (IbaI, 1:500, Novus, #NBP2-19019; GFAP, 1:400, CST, #12389; NeuN, 1:400, CST, #24307; LCN2, 1:500, R&D Systems, #AF1857) in PBS containing 1% BSA at 4 ºC overnight. After washing 4 times for 5 min in PBS, sections were incubated with secondary antibody (TRITC-conjugated donkey anti-rabbit or AF488-conjugated donkey anti-goat, 1:400) for 1 h at room temperature. Sections were then washed in PBS, incubated with DAPI (1:1000, CST, #4083) in PBS for 10 min. Subsequently, sections were washed in PBS buffer, mounted onto microscope slides with anti-fade mounting medium (Solarbio, #S2100).

Image acquisition

All images were acquired using a 10 X or 20 X objective lens on a confocal microscope (Nikon A1). Images were collected with an image matrix of 1024 × 1024 pixels.

Sholl analysis

Images were opened by ImageJ software (USA, National Institute of Health). Z-stack was applied to collect 20-μm-thickness images (n = 4 mice/group, 9 image stacks per animal). Single microglia were isolated and thresholded manually [53]. Then, using Sholl analysis plugin, set the first shell with 5 μm and subsequent shells at 2-μm step size, and get intersection numbers at each Sholl radius. Ramification index is defined as the ratio of the perimeter to the area, normalized by that same ratio calculated for a circle of the same area. Specifically, R = (perimeter/area)/[2⁎(π/area)1/2]. Thus, R = 1 if the cell is a perfect circle, the larger R, the more ramified the cell. All analysis was carried out by an experienced researcher who was blinded to the experimental conditions.


Graphical and statistical analyses were conducted in GraphPad 6.0 (Prism Software Inc., CA, USA). Data are presented as means ± standard error of the mean (SEM). Tests for differences between two populations were performed using unpaired two-tail Student’s t test. Multiple-group comparison was performed with one-way ANOVA followed by a Bonferroni’s post hoc test. No data points were excluded from the statical analysis. Significance was set at P < 0.05.


Tibial surgery leads to cognitive decline and LCN2 elevation in hippocampus

To investigate the mechanisms of PNDs, an aseptic tibial fracture surgery model 28 was established and cognitive functions were assessed in a trace-fear conditioning (TFC) paradigm and Novel Object Recognition (NOR) task (Fig. 1a, b). Compared with anesthesia-matched sham procedure, surgery induced memory decline in mice as evidenced by a significant reduction in freezing time (Fig. 1a). In NOR test, we found surgery had no effects on the animals’ spontaneous locomotor activity and exploration behavior, as evidenced by similar total exploration time between groups (Additional file 1: Fig. S1a). Notably, mice in Surgery group had lower discrimination ratio than Sham group, suggesting impaired recognition memory (Fig. 1b).

Fig. 1
figure 1

Tibial surgery leads to cognitive decline and LCN2 elevation in hippocampus. a Upper panel, cartoon depicting the TFC behavior paradigm. Lower panel, percent of time spent in freezing behavior (n = 12 mice/group). b Upper panel, cartoon depicting the NOR test paradigm. Lower panel, discrimination ratio during novel phase (n = 8 mice in Sham group, n = 7 mice in Surgery group). c Upper panel, samples were collected in another cohort at time points of 6 h, 24 h and 3 days, respectively. Lower panel, relative expression of Lcn2 mRNA at 6 h after surgery (n = 5 mice/group). d Tissue ELISA test of LCN2 in hippocampus (n = 3–6 mice/group). e LCN2 level correlates with IL-6 level in hippocampus at 6 h. Data are represented as mean ± SEM, * P < 0.05, ** P < 0.01; *** P < 0.001

In our previous genome-wide RNA-seq study, we identified Lcn2 as one of the top upregulated genes in the mouse hippocampus after surgery [28],. Here, qPCR analysis confirmed the upregulation of Lcn2 mRNA in the hippocampus (Fig. 1c). ELISA analysis showed that the amount of LCN2 protein was elevated at 6 h after surgery (Fig. 1d), and then returned to the baseline level 3 days after surgery. Correlation analysis showed that LCN2 level was positively correlated with IL-6 level in the hippocampus at 6 h (Fig. 1e). Meanwhile, ELISA analysis showed elevation of blood IL-6 which was consistent with previously reported (Additional file 1: Fig. S1b) [29], and LCN2 was also elevated in blood (Additional file 1: Fig. S1c). In this study, we only focused on the brain cellular source of LCN2.

LCN2 is mainly expressed in neurons

To characterize the cellular source of LCN2, mouse brains were dissected at 24 h after surgery then processed for immunofluorescence histochemistry (Fig. 2a). More than 80% of LCN2+ cells were co-labeled with NeuN (Fig. 2b), suggesting LCN2 was mainly expressed in neurons but not microglia or astrocytes. In a parallel experiment, CD11b+ microglia cells and CD11b cells were isolated by MACS (magnetic activated cell sorting) (Fig. 2c). Sorting purity was verified by cx3cr1 expression level (Fig. 2d). Like immunofluorescence histochemistry analysis, qPCR analysis verified that Lcn2 was expressed higher in CD11b cells than CD11b+ cells (Fig. 2e). Meanwhile, compared with Sham group, the expression of IL-6 was upregulated in CD11b+ cells in Surgery group (Fig. 2f), suggesting that microglia were switched to a proinflammatory phenotype.

Fig. 2
figure 2

LCN2 mainly expressed on neurons. a Representative immunofluorescence images of LCN2 (green), GFAP (red), NeuN (red) and IbaI (red) staining in sections of the hippocampus after surgery. Long scale bar, 600 µm; short scale bar, 25 µm. b Percentage quantification of LCN2 positive cells (n = 3 mice/group). c Cartoon depicting MACS sorting procedures for isolating CD11b+ and CD11b cells. d Relative expression of cx3cr1 in CD11b + and CD11b cells after sorting from all samples. d Relative expression level of Lcn2 mRNA in CD11b + and CD11b cells from hippocampus 6 h after surgery. e Relative expression level of IL-6 mRNA in CD11b + cells. Data are represented as mean ± SEM. **** P < 0.0001

Elevation of LCN2 is independent of the presence of microglia

Next, we sought to determine whether the elevation of LCN2 after surgery requires microglia. CSF1R inhibitor and genetical models were commonly used approaches to effectively deplete microglia. Previous studies have shown that continuous application of CSF1R inhibitor reduces more than 30% of circulating cx3cr1+ monocytes [35] which have been reported to be critical in peripheral immune activation induced learning deficits[35]34. To avoid this, cx3cr1CreER/+:: R26iDTR/+ model was used in this study to selectively ablate microglia without affecting peripheral cx3cr1+ monocyte population 34,35. Induction of diphtheria toxin receptor (DTR) expression in cx3cr1+ cells was achieved by oral gavage of tamoxifen, leaving only microglia sensitive to DT-induced cell death after spacing a ~week period during which peripheral monocytes were renewed (Fig. 3a). After continuous 3 days of DT administration, IbaI immuno-histochemistry confirmed that more than 90% of microglia in hippocampus were depleted (Fig. 3b, c). LCN2 was still elevated after surgery after microglia depletion (Fig. 3d). In addition, the amount of IL-6 in the brain was decreased compared with the group with microglia intact (Fig. 3e), while the level of circulating IL-6 was comparable to that in microglia-intact group (Fig. 3f), suggesting activated microglia is a major contributor of neuroinflammation. Finally, in mice without microglia, cognitive function was preserved after surgery, as evidenced by increased freezing time (Fig. 3g). These data suggest that elevation of LCN2 after surgery is independent of the presence of microglia, and cognitive decline is dependent on the presence of microglia.

Fig. 3
figure 3

Elevation of LCN2 is independent of the presence of microglia. a Schematics of microglia depletion in cx3cr1CreER±:: R26iDTR± mice. Vehicle: corn oil; TAM: tamoxifen dissolved in corn oil. b Representative brain sections with IbaI+ cells (green). Scale bars, 350 µm. c Quantification of the microglia density in b (n = 2 mice/group). d Tissue ELISA of LCN2 at 6 h after surgery (n = 5 mice/group). e Tissue ELISA of IL-6 at 6 h after surgery (n = 5 mice/group). f Serum ELISA of IL-6 at 6 h or 24 h after surgery (n = 5 mice/group). g Percent of time spent in freezing behavior (n = 12 mice/group). Data are represented as mean ± SEM; NS, no significance; ** P < 0.01; **** P < 0.0001

LCN2 mediates cognitive dysfunction after surgery

Next, rLCN2 protein was bilaterally injected into the CA1 region of the mouse hippocampus immediately after TFC training. Memory performance was impaired as evidenced by decreased freezing time (Fig. 4a). To selectively deplete LCN2, three AAV-shRNA viral constructs were designed on different targeting sequences; a random sequence-scrambled shRNA-expressing AAV vector was used as a control. One of the most effective knocking down constructs was selected in this study (data not shown). To ensure effective expression, AAV viruses were bilaterally delivered into the CA1 region (LCN2-AAV: ~ 6.25 × 1012 GC/mL titer; Control-AAV: ~ 8.0 × 1012 GC/mL titer. 200 nL for each hemisphere) (Fig. 4b). Three weeks later, extensive transfection was found in neurons (> 95%), but not astrocytes nor microglia (Additional file 1: Fig. S2). qPCR and ELISA analysis verified the silencing effect of Lcn2 (Fig. 4c, d). Freezing time was increased after knocking down of LCN2 when compared with Control-AAV group after surgery (Fig. 4e), indicating cognitive decline was ameliorated. These data suggest LCN2 mediates cognitive dysfunction after surgery.

Fig. 4
figure 4

LCN2 mediates cognitive dysfunction after surgery. a Upper, scheme timeline for rLCN2 intracranial injection and TFC behavior test; lower, percent of time spent in freezing behavior (n = 8 mice in Vehicle group, n = 9 in rLCN2 group). Vehicle: PBS buffer. b Upper, constructs of the LCN2-AAV and Control-AAV; lower, scheme timeline for TFC behavior test and sample collections. c Relative expression of Lcn2 mRNA at 6 h after surgery (n = 5 mice/ group). d Tissue ELISA of LCN2 level in hippocampus at 6 h after surgery (n = 5 mice/group). e Percent of time spent in freezing behavior (n = 12 mice/group). Data are represented as mean ± SEM, * P < 0.05; ** P < 0.01

Knockdown of LCN2 prevents microglial activation and neuroinflammation

Recent studies suggest that microglia might play an important role in the development of PNDs [23,36], but the up- and down-stream mechanisms are far less clear. As we observed increased expression of LCN2 in neurons, we sought to examine the response of microglia to LCN2.

Immunostaining of hippocampal slices against Iba-I was performed at 24 h after surgery (Fig. 5a). Microglial cell density remained unchanged (Fig. 5b). To quantify the complexity of microglia processes, ramification index was calculated (see Methods). Microglial ramification index in Surgery group was lower than Sham group, which was mitigated in LCN2-AAV group but not in Control-AAV group (Fig. 5c). Sholl analysis revealed that microglia in Surgery group had fewer process intersections with shells at different radii from cell soma when compared with Sham group, which was alleviated in LCN2-AAV group but not Control-AAV group (Fig. 5d). In addition, silencing LCN2 reduced the elevation of IL-6 in the mouse hippocampus after surgery (Fig. 5e). In in vitro experiments, rLCN2 were applied to BV-2 cell line and primary microglia cell culture, respectively. qPCR analysis found the expression of several proinflammatory cytokines including tnf-α, IL-6, IL-1β were elevated (Fig. 5f). These data suggest that silencing LCN2 prevented surgery induced switching of microglia to proinflammatory state and following neuroinflammation.

Fig. 5
figure 5

Knockdown of LCN2 prevents microglial activation and neuroinflammation. a Representative immunofluorescence images of hippocampal sections with IbaI+ cells (White). Scale bars, 150 µm. b Quantification of the microglia density in (A) (n = 4 mice/group, 2–3 slides/mice). c Quantification of the microglia Ramification index at 24 h after surgery (n = 72 cells from 4 mice/group). d Number of process intersections with shells at distances (in 2 µm in increments) from the soma by Sholl analysis at 24 h after surgery (n = 72 cells from 4 mice/group). e Tissue ELISA of IL-6 at 24 h after surgery (n = 5 mice/group). f Relative expression level of tnf-α, IL-6 and/or IL-1β 6 h after application of rLCN2 (500 ng/mL) on BV-2 (n = 4–6/group) and primary microglia cells (n = 3/group). Vehicle: PBS buffer. Data represent mean ± SEM; n = 4/group. * P < 0.05; *** P < 0.001


In this study, we provided several lines of evidence supporting the hypothesis that LCN2 serves as a signal from neuron to evoke proinflammatory microglia, contributing to surgery-induced neuroinflammation in hippocampus and memory deficits in mice. Firstly, by immuno-histology, MACS sorting and/or qPCR analysis, we showed that LCN2 was robustly expressed in hippocampal neurons and IL-6 was upregulated in microglia after surgery. Furthermore, by performing microglia depletion in vivo, we demonstrated that surgery-induced cognitive decline is dependent on the presence of microglia, while LCN2 upregulation was independent of the presence of microglia. By immune-staining and Sholl analysis, we found that after surgery, microglia were not changed in cell density in the brain but exhibit a less ramified morphology; by gain and loss of function of LCN2, we revealed that LCN2 mediates surgery-induced microglia activation and cognitive decline. Last but not least, we show that application of LCN2 elicits an proinflammatory microglia phenotype in vitro.

Although we demonstrated a robust elevation of LCN2, we did not investigate what signals trigger the expression of LCN2. Searching the regulatory upstream sequences, CCAAT-enhancer-binding site (C/EBPs), NF-kB-binding site, glucocorticoid response elements (GREs), STAT1 and STAT3 site are identified, thus numerous factors during surgery such as released DAMPs cocktail and/or surgical stress might synergically contribute to the elevation of LCN2. In a separate in vitro experiment, we found a marked elevation and secretion of LCN2 protein after application of LPS (a TLR4 activator) on a murine neuroblastoma cell line N2A (data not shown), suggesting the existence of the LCN2 regulation pathway in neurons.

LCN2 is initially described as a beneficial signaling involved in infectious diseases [27], the role of LCN2 in the context of non-infectious conditions is less clear.

The expression level of LCN2 is quite low in normal adult brain and elevated in many central nervous system diseases, but the source of LCN2 could come from different lines of cells such as astrocyte [37], endothelia cell [38] or neuron [39]. Our data showed that after surgery, 86% of LCN2+ cells were neurons and only 11.2% LCN2+ cells were astrocytes. Several reports revealed a detrimental role of LCN2, including impairing synaptic plasticity [40], promoting neuron death [37], or acting in a pro-inflammatory manner during ischemia [41, 42] and Alzheimer’s disease [43], and polarizing microglia toward pro-inflammatory phenotype [44, 45]. However, evidence have also shown that LCN2 may play a beneficial role in experimental autoimmune encephalomyelitis [46, 47] and sepsis models [48]. In this study, our data demonstrate a neurotoxic potential role of surgery procedure-induced neuronal LCN2, and a single dose of rLCN2 administered intracranially could lead to cognitive decline. These data are in contrast with previous reports [49], which showed that only chronic but not acute rLCN2 treatment impairs cognitive function. These discordant results can arise because of different experiment conditions such as dosage/timing of administration and behavior paradigms used. Meanwhile, limitations existed, regarding the large amount of the co-staining of LCN2 with NeuN, it raised a possibility that the other cells like astrocyte secreted or blood-derived LCN2 may also contribute to PNDs.

Microglia possess many receptors to recognize danger signals, clear cell debris and respond rapidly to changes in brain parenchyma. Accumulating evidence showed that microglia plays a central role in many neurodegenerative diseases including PNDs. Our data showed that knocking down of LCN2 could prevent microglia morphological changes and alleviates neuroinflammation after surgery. In in vitro studies, application of rLCN2 evokes proinflammatory-phenotype of microglia, but detailed mechanisms remain to be determined. Previous study showed that LCN2 promotes microglia to release inflammatory cytokines[44]. Another study showed that LCN2 could enhance priming and activation of NLRP3-inflammasome and induce mitochondria dysfunction to release reactive oxygen species in cardiac cells [50]. Meanwhile, it is also suggested that LCN2 might induce chemokine expression then activates microglia further [51]. Evaluating more cytokines and cell responses to LCN2 would provide more insights into the mechanisms underlying the effects of LCN2 on microglia.


In conclusion, our previous and present studies demonstrated Lcn2 was screened as one of the top upregulated genes in neurons after surgery. By MACS, microglia depletion, gain and loss function of LCN2, combining with in vitro experiments, we demonstrated that LCN2 might serve as a signal from neuron to microglia and contribute to the development of neuroinflammation and cognitive decline. Our findings open new avenues for research aimed at investigating pathophysiological mechanisms and developing therapeutic targets on PNDs.

Data availability

All data used in this study are available upon reasonable request.



Perioperative neurocognitive disorders




Glial fibrillary acidic protein


Neuronal nuclear protein


Cre recombinase-estrogen receptor fusion protein


Diphtheria toxin receptor


Diphtheria toxin


Short hairpin RNA


Dulbecco's modified Eagle medium


Bicinchoninic acid


Hanks' balanced salt solution




  1. Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, Rabbitt P, Jolles J, Larsen K, Hanning CD et al: Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet (London, England) 1998, 351(9106):857–861.

  2. Bedford PD. Adverse cerebral effects of anaesthesia on old people. Lancet (London, England). 1955;269(6884):259–63.

    Article  CAS  Google Scholar 

  3. Evered L, Silbert B, Knopman DS, Scott DA, DeKosky ST, Rasmussen LS, Oh ES, Crosby G, Berger M, Eckenhoff RG, et al. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. Br J Anaesth. 2018;121(5):1005–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Monk TG, Weldon BC, Garvan CW, Dede DE, Van Der Aa MT, Heilman KM, Gravenstein JS. Predictors of cognitive dysfunction after major noncardiac surgery. J Am Soc Anesthesiol. 2008;108(1):18–30.

    Article  Google Scholar 

  5. McDonagh DL, Mathew JP, White WD, Phillips-Bute B, Laskowitz DT, Podgoreanu MV, Newman MF, Group NOR. Cognitive function after major noncardiac surgery, apolipoprotein E4 genotype, and biomarkers of brain injury. J Am Soc Anesthesiol. 2010;112(4):852–9.

    Google Scholar 

  6. Robinson TN, Raeburn CD, Tran ZV, Angles EM, Brenner LA, Moss M. Postoperative delirium in the elderly: risk factors and outcomes. Ann Surg. 2009;249(1):173–8.

    Article  PubMed  Google Scholar 

  7. Marcantonio ER, Flacker JM, Michaels M, Resnick NM. Delirium is independently associated with poor functional recovery after hip fracture. J Am Geriatr Soc. 2000;48(6):618–24.

    Article  CAS  PubMed  Google Scholar 

  8. Wang P, Velagapudi R, Kong C, Rodriguiz RM, Wetsel WC, Yang T, Berger M, Gelbard HA, Colton CA, Terrando N. Neurovascular and immune mechanisms that regulate postoperative delirium superimposed on dementia. Alzheimers Dement. 2020;16(5):734–49.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Saczynski JS, Marcantonio ER, Quach L, Fong TG, Gross A, Inouye SK, Jones RN. Cognitive trajectories after postoperative delirium. N Engl J Med. 2012;367(1):30–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Evered L, Silbert B, Scott DA, Ames D, Maruff P, Blennow K. Cerebrospinal fluid biomarker for Alzheimer disease predicts postoperative cognitive dysfunction. Anesthesiology. 2016;124(2):353–61.

    Article  CAS  PubMed  Google Scholar 

  11. Huber-Lang M, Lambris JD, Ward PA. Innate immune responses to trauma. Nat Immunol. 2018;19(4):327–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Subramaniyan S, Terrando N. Neuroinflammation and perioperative neurocognitive disorders. Anesth Analg. 2019;128(4):781–8.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Yang T, Velagapudi R, Terrando N. Neuroinflammation after surgery: from mechanisms to therapeutic targets. Nat Immunol. 2020;21(11):1319–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Alam A, Hana Z, Jin Z, Suen KC, Ma D. Surgery, neuroinflammation and cognitive impairment. EBioMedicine. 2018;37:547–56.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Safavynia SA, Goldstein PA. The role of neuroinflammation in postoperative cognitive dysfunction: moving from hypothesis to treatment. Front Psychiatry. 2019;9:752–752.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Yang S, Gu C, Mandeville ET, Dong Y, Esposito E, Zhang Y, Yang G, Shen Y, Fu X, Lo EH, et al. Anesthesia and surgery impair blood-brain barrier and cognitive function in mice. Front Immunol. 2017;8:902.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Schuitemaker A, Dik MG, Veerhuis R, Scheltens P, Schoonenboom NS, Hack CE, Blankenstein MA, Jonker C. Inflammatory markers in AD and MCI patients with different biomarker profiles. Neurobiol Aging. 2009;30(11):1885–9.

    Article  CAS  PubMed  Google Scholar 

  18. Tang JX, Baranov D, Hammond M, Shaw LM, Eckenhoff MF, Eckenhoff RG. Human Alzheimer and inflammation biomarkers after anesthesia and surgery. Anesthesiology. 2011;115(4):727–32.

    Article  CAS  PubMed  Google Scholar 

  19. Bromander S, Anckarsater R, Kristiansson M, Blennow K, Zetterberg H, Anckarsater H, Wass CE. Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study. J Neuroinflammation. 2012;9:242.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Pikwer A, Castegren M, Namdar S, Blennow K, Zetterberg H, Mattsson N. Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study. J Neuroinflammation. 2017;14(1):193.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Terrando N, Monaco C, Ma D, Foxwell BM, Feldmann M, Maze M. Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci USA. 2010;107(47):20518–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Degos V, Vacas S, Han Z, van Rooijen N, Gressens P, Su H, Young WL, Maze M: Depletion of bone marrow–derived macrophages perturbs the innate immune response to surgery and reduces postoperative memory dysfunction. Anesthesiology 2013, 118(3):527–536–527–536.

  23. Cibelli M, Fidalgo AR, Terrando N, Ma D, Monaco C, Feldmann M, Takata M, Lever IJ, Nanchahal J, Fanselow MS, et al. Role of interleukin-1beta in postoperative cognitive dysfunction. Ann Neurol. 2010;68(3):360–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Feng X, Valdearcos M, Uchida Y, Lutrin D, Maze M, Koliwad SK. Microglia mediate postoperative hippocampal inflammation and cognitive decline in mice. JCI Insight. 2017;2(7):e91229.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Hu J, Feng X, Valdearcos M, Lutrin D, Uchida Y, Koliwad SK, Maze M. Interleukin-6 is both necessary and sufficient to produce perioperative neurocognitive disorder in mice. Br J Anaesth. 2018;120(3):537–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Garay-Rojas E, Harper M, Hraba-Renevey S, Kress M. An apparent autocrine mechanism amplifies the dexamethasone- and retinoic acid-induced expression of mouse lipocalin-encoding gene 24p3. Gene. 1996;170(2):173–80.

    Article  CAS  PubMed  Google Scholar 

  27. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432(7019):917–21.

    Article  CAS  PubMed  Google Scholar 

  28. Ferreira AC, Da Mesquita S, Sousa JC, Correia-Neves M, Sousa N, Palha JA, Marques F. From the periphery to the brain: Lipocalin-2, a friend or foe? Prog Neurobiol. 2015;131:120–36.

    Article  CAS  PubMed  Google Scholar 

  29. Xiang X, Yu Y, Tang X, Chen M, Zheng Y, Zhu S. Transcriptome Profile in Hippocampus during Acute Inflammatory Response to Surgery: Toward Early Stage of PND. Front Immunol. 2019;10:149.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Gouweleeuw L, Hovens IB, van Leeuwen BL, Schoemaker RG. Neutrophil gelatinase-associated lipocalin and microglial activity are associated with distinct postoperative behavioral changes in rats. Behav Brain Res. 2017;319:104–9.

    Article  CAS  PubMed  Google Scholar 

  31. Kálmán J, Juhász A, Bogáts G, Babik B, Rimanóczy Á, Janka Z, Penke B, Palotás A. Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary artery bypass surgery are predictors of cognitive decline. Neurochem Int. 2006;48(3):177–80.

    Article  CAS  PubMed  Google Scholar 

  32. Llorens F, Hermann P, Villar-Piqué A, Diaz-Lucena D, Nägga K, Hansson O, Santana I, Schmitz M, Schmidt C, Varges D. Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia. Nat Commun. 2020;11(1):1–11.

    Article  CAS  Google Scholar 

  33. Choi J, Lee HW, Suk K. Increased plasma levels of lipocalin 2 in mild cognitive impairment. J Neurol Sci. 2011;305(1–2):28–33.

    Article  CAS  PubMed  Google Scholar 

  34. Eruysal E, Ravdin L, Kamel H, Iadecola C, Ishii M. Plasma lipocalin-2 levels in the preclinical stage of Alzheimer’s disease. Alzheimer’s Dementia. 2019;11:646–53.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Garré JM, Silva HM, Lafaille JJ, Yang G: CX3CR1(+) monocytes modulate learning and learning-dependent dendritic spine remodeling via TNF-α. 2017, 23(6):714–722.

  36. Parkhurst CN, Yang G, Ninan I, Savas JN, Yates JR III, Lafaille JJ, Hempstead BL, Littman DR, Gan W-B. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013;155(7):1596–609.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Bi F, Huang C, Tong J, Qiu G, Huang B, Wu Q, Li F, Xu Z, Bowser R, Xia X-G. Reactive astrocytes secrete lcn2 to promote neuron death. Proc Natl Acad Sci. 2013;110(10):4069–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Marques F, Rodrigues A-J, Sousa JC, Coppola G, Geschwind DH, Sousa N, Correia-Neves M, Palha JA. Lipocalin 2 is a choroid plexus acute-phase protein. J Cereb Blood Flow Metab. 2008;28(3):450–5.

    Article  CAS  PubMed  Google Scholar 

  39. Xing C, Wang X, Cheng C, Montaner J, Mandeville E, Leung W, van Leyen K, Lok J, Wang X, Lo EH. Neuronal production of lipocalin-2 as a help-me signal for glial activation. Stroke. 2014;45(7):2085–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Mucha M, Skrzypiec AE, Schiavon E, Attwood BK, Kucerova E, Pawlak R. Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation. Proc Natl Acad Sci USA. 2011;108(45):18436–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Jin M, Kim JH, Jang E, Lee YM, Soo Han H, Woo DK, Park DH, Kook H, Suk K. Lipocalin-2 deficiency attenuates neuroinflammation and brain injury after transient middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab. 2014;34(8):1306–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Wang G, Weng YC, Han X, Whaley JD, McCrae KR, Chou WH. Lipocalin-2 released in response to cerebral ischaemia mediates reperfusion injury in mice. J Cell Mol Med. 2015;19(7):1637–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Naudé PJ, Nyakas C, E. Eiden L, Ait‐Ali D, van der Heide R, Engelborghs S, Luiten PG, De Deyn PP, den Boer JA, Eisel UL: Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. FASEB J 2012, 26(7):2811–2823.

  44. Jang E, Lee S, Kim JH, Kim JH, Seo JW, Lee WH, Mori K, Nakao K, Suk K. Secreted protein lipocalin-2 promotes microglial M1 polarization. FASEB J. 2013;27(3):1176–90.

    Article  CAS  PubMed  Google Scholar 

  45. Lee S, Lee J, Kim S, Park J-Y, Lee W-H, Mori K, Kim S-H, Kim IK, Suk K. A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J Immunol. 2007;179(5):3231–41.

    Article  CAS  PubMed  Google Scholar 

  46. Nam Y, Kim JH, Seo M, Kim JH, Jin M, Jeon S, Seo JW, Lee WH, Bing SJ, Jee Y, et al. Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues. J Biol Chem. 2014;289(24):16773–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Berard JL, Zarruk JG, Arbour N, Prat A, Yong VW, Jacques FH, Akira S, David S. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Glia. 2012;60(7):1145–59.

    Article  PubMed  Google Scholar 

  48. Kang SS, Ren Y, Liu C-C, Kurti A, Baker KE, Bu G, Asmann Y, Fryer JD. Lipocalin-2 protects the brain during inflammatory conditions. Mol Psychiatry. 2018;23(2):344–50.

    Article  CAS  PubMed  Google Scholar 

  49. Olson B, Zhu X, Norgard MA, Diba P, Levasseur PR, Buenafe AC, Huisman C, Burfeind KG, Michaelis KA, Kong G. Chronic cerebral lipocalin 2 exposure elicits hippocampal neuronal dysfunction and cognitive impairment. Brain Behav Immun. 2021;97:102–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Song E, Jahng JW, Chong LP, Sung HK, Han M, Luo C, Wu D, Boo S, Hinz B, Cooper MA. Lipocalin-2 induces NLRP3 inflammasome activation via HMGB1 induced TLR4 signaling in heart tissue of mice under pressure overload challenge. Am J Transl Res. 2017;9(6):2723.

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Jeon S, Jha MK, Ock J, Seo J, Jin M, Cho H, Lee WH, Suk K. Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury. J Biol Chem. 2013;288(33):24116–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references


Not applicable.


This work was supported by grants from the National Natural Science Foundation of China 81771194, 81971008 (to ZSM).

Author information

Authors and Affiliations



XXW, YG, GSY and ZSM conceived and designed the experiments; XXW, TXD, YY, XSL, LL, CML and ZR performed the experiments; XXW, TXD, YY, KXH, ZYY, GSY and ZSM analyzed the data; XXW, TXD, YY, YG and ZSM wrote the paper. All authors read and approved of the final manuscript.

Corresponding authors

Correspondence to Shuyuan Gan or Shengmei Zhu.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Additional file 1: Fig. S1.

Exploration time in NOR test and elevated cytokines after surgery. a Total exploration time in NOR test was calculated as total time spent on exploring familiar and novel objects (n = 8 mice in Sham group, n = 7 in Surgery group). b Serum ELISA of IL-6 level at 6 h and 24 h (n = 3–6 mice/group). c Serum ELISA of LCN2 level at 6 h and 24 h (n = 3–5 mice/group). Data represent mean ± SEM; * P < 0.05, ** P < 0.01, *** P < 0.001. Fig. S2. AAV infection in hippocampus and primary microglia cell culture. a Representative immunofluorescence images of hippocampal sections labeling with neuron (NeuN, red), astrocyte (GFAP, red), microglia (IbaI, red) and AAV infection (eGFP, green). Scale bar, 200 µm. b Representative immunofluorescence images of primary microglia culture (blue: DAPI; red: IbaI). Scale bar, 250 µm.

Additional file 2: Table S1.

Primer sequence.

Additional file 3: Table S2.

Targeting sequence of AAV for Knockdown of LCN2.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiang, X., Tang, X., Yu, Y. et al. Role of lipocalin-2 in surgery-induced cognitive decline in mice: a signal from neuron to microglia. J Neuroinflammation 19, 92 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: